Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
266
-
Total 13F shares, excl. options
-
106M
-
Shares change
-
-2.88M
-
Total reported value, excl. options
-
$3.89B
-
Value change
-
-$66.5M
-
Put/Call ratio
-
0.75
-
Number of buys
-
97
-
Number of sells
-
-159
-
Price
-
$36.64
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2016
349 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2016.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 266 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 106M shares
of 159M outstanding shares and own 67.07% of the company stock.
Largest 10 shareholders include FMR LLC (18.1M shares), Clearbridge Investments, LLC (10.8M shares), VANGUARD GROUP INC (8.79M shares), BAILLIE GIFFORD & CO (8.48M shares), BB BIOTECH AG (7.16M shares), WADDELL & REED FINANCIAL INC (5.81M shares), STATE STREET CORP (3.58M shares), WELLINGTON MANAGEMENT GROUP LLP (3.09M shares), BlackRock Institutional Trust Company, N.A. (2.98M shares), and BlackRock Fund Advisors (2.88M shares).
This table shows the top 266 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.